69 phenotypes from 6 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Hnf1btm1Ics/Hnf1b+ Wnt4tm2(EGFP/cre)Svo/Wnt4+ involves: 129P2/OlaHsd	abnormal renal tubule morphology	J:194051
	renal glomerulus cyst	J:194051
Hnf1btm1Ics/Hnf1btm1Sce Wnt4tm2(EGFP/cre)Svo/Wnt4+ involves: 129P2/OlaHsd	abnormal kidney morphology	J:194051
	abnormal loop of Henle morphology	J:194051
	abnormal metanephros morphology	J:194051
	abnormal proximal convoluted tubule morphology	J:194051
	abnormal renal tubule morphology	J:194051
	hydronephrosis	J:194051
	postnatal lethality, complete penetrance	J:194051
	renal glomerulus cyst	J:194051
Hnf1btm1Mya/Hnf1btm1Mya involves: 129S2/SvPas	abnormal visceral endoderm morphology	J:58080
	absent blastocoele	J:58080
	decreased embryo size	J:58080
	disorganized embryonic tissue	J:58080
	disorganized extraembryonic tissue	J:58080
	embryonic growth arrest	J:58080
	embryonic lethality between implantation and somite formation, complete penetrance	J:58080
	failure to gastrulate	J:58080
Hnf1btm1Mya/Hnf1btm3Mya Tg(Alb1-cre)7Gsc/0 involves: 129S2/SvPas * C57BL/6 * FVB/N	abnormal bile duct physiology	J:75935
	abnormal cystic duct morphology	J:75935
	abnormal extrahepatic bile duct morphology	J:75935
	abnormal gallbladder epithelium morphology	J:75935
	abnormal hepatobiliary system morphology	J:75935
	abnormal hepatobiliary system physiology	J:75935
	abnormal interlobular bile duct morphology	J:75935
	abnormal intrahepatic bile duct morphology	J:75935
	abnormal lipid homeostasis	J:75935
	cachexia	J:75935
	decreased body size	J:75935
	decreased body weight	J:75935
	decreased liver function	J:75935
	enlarged liver	J:75935
	hepatic necrosis	J:75935
	increased circulating bilirubin level	J:75935
	increased circulating cholesterol level	J:75935
	increased circulating triglyceride level	J:75935
	intrahepatic cholestasis	J:75935
	jaundice	J:75935
	liver inflammation	J:75935
	muscular atrophy	J:75935
	postnatal growth retardation	J:75935
	premature death	J:75935
Hnf1btm1Sce/Hnf1b+ Wnt4tm2(EGFP/cre)Svo/Wnt4+ involves: 129P2/OlaHsd	normal renal/urinary system phenotype	J:194051
Hnf1btm1Sce/Hnf1btm1Sce either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * C57BL/6J * DBA/2)	abnormal developmental patterning	J:58079
	abnormal ectoderm development	J:58079
	abnormal embryonic epiblast morphology	J:58079
	abnormal embryonic tissue morphology	J:58079
	abnormal extraembryonic tissue morphology	J:58079
	abnormal inner cell mass morphology	J:58079
	abnormal primitive endoderm morphology	J:58079
	absent ectoplacental cavity	J:58079
	absent parietal endoderm	J:58079
	absent proamniotic cavity	J:58079
	absent visceral endoderm	J:58079
	decreased embryo size	J:58079
	embryonic growth arrest	J:58079
	embryonic growth retardation	J:58079
	embryonic lethality between implantation and somite formation, complete penetrance	J:58079
Hnf1btm2Ics/Hnf1b+ involves: 129 * C57BL/6N	abnormal pancreatic duct morphology	J:306082
	chronic pancreas inflammation	J:306082
	decreased circulating insulin level	J:306082
	decreased insulin secretion	J:306082
	decreased pancreatic acinar cell number	J:306082
	decreased pancreatic islet number	J:306082
	normal homeostasis/metabolism phenotype	J:306082
	hyperglycemia	J:306082
	impaired glucose tolerance	J:306082
	increased fasting circulating glucose level	J:306082
	pancreas fibrosis	J:306082
	pancreas lipomatosis	J:306082
	pancreatic acinar hypoplasia	J:306082
	pancreatic acinar-to-ductal metaplasia	J:306082
	small pancreatic islets	J:306082
Hnf1btm2Mya/Hnf1btm2Mya involves: 129S2/SvPas	abnormal extraembryonic endoderm formation	J:58080
	absent blastocoele	J:58080
	decreased embryo size	J:58080
	disorganized embryonic tissue	J:58080
	disorganized extraembryonic tissue	J:58080
	embryonic growth arrest	J:58080
	embryonic lethality between implantation and somite formation, complete penetrance	J:58080
	failure to gastrulate	J:58080